Cargando…
Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries. Protein tyrosine phosphatase 1B (PTP1B), a negative modulator of insulin and cytokine signaling, is a therapeutic target for type 2 diabetes and obesity. We investigated the impact of...
Autores principales: | González-Rodríguez, Águeda, Valdecantos, M. Pilar, Rada, Patricia, Addante, Annalisa, Barahona, Inés, Rey, Esther, Pardo, Virginia, Ruiz, Laura, Laiglesia, Laura M., Moreno-Aliaga, María J., García-Monzón, Carmelo, Sánchez, Aránzazu, Valverde, Ángela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784331/ https://www.ncbi.nlm.nih.gov/pubmed/29126873 http://dx.doi.org/10.1016/j.molmet.2017.10.008 |
Ejemplares similares
-
Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases
por: García-Ruiz, Inmaculada García, et al.
Publicado: (2019) -
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
por: Rada, Patricia, et al.
Publicado: (2020) -
Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress
por: Brea, Rocío, et al.
Publicado: (2021) -
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy
por: Valdecantos, M. Pilar, et al.
Publicado: (2018) -
Protection against gamma-radiation injury by protein tyrosine phosphatase 1B
por: Mojena, Marina, et al.
Publicado: (2018)